BCAX Financials

Bicara Therapeutics Inc - Financial statements & key metrics

Stock Price

$21.47

Market Cap

$1.41B

EPS

$-2.52

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-68.00M

EPS (Diluted)

$-4.05

Balance Sheet Highlights

Total Assets

$510.00M

Total Liabilities

$18.12M

Shareholders Equity

Cash & Equivalents

$489.71M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-74.75M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-0.3%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is BCAX revenue?

View BCAX's income statement for detailed revenue data.

Is BCAX profitable?

BCAX reported a loss of $68.00M in the most recent quarter.

What is BCAX market cap?

BCAX has a market capitalization of $1.41B, making it a small-cap stock.

Does BCAX have debt?

View BCAX's balance sheet for debt information.

What is BCAX cash flow?

Cash flow data is available in the full financial statements.